American Century Companies’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-214,592
| Closed | -$5.12M | – | 1768 |
|
2019
Q4 | $5.12M | Buy |
214,592
+76,337
| +55% | +$1.82M | ﹤0.01% | 805 |
|
2019
Q3 | $3.71M | Buy |
138,255
+8,279
| +6% | +$222K | ﹤0.01% | 864 |
|
2019
Q2 | $3.53M | Buy |
129,976
+39,429
| +44% | +$1.07M | ﹤0.01% | 911 |
|
2019
Q1 | $3.14M | Buy |
+90,547
| New | +$3.14M | ﹤0.01% | 922 |
|
2018
Q3 | – | Sell |
-80,698
| Closed | -$3.05M | – | 1386 |
|
2018
Q2 | $3.05M | Buy |
80,698
+6,383
| +9% | +$241K | ﹤0.01% | 942 |
|
2018
Q1 | $2.43M | Buy |
74,315
+13,667
| +23% | +$446K | ﹤0.01% | 969 |
|
2017
Q4 | $2.95M | Buy |
60,648
+9,275
| +18% | +$451K | ﹤0.01% | 946 |
|
2017
Q3 | $2.78M | Sell |
51,373
-1,867
| -4% | -$101K | ﹤0.01% | 981 |
|
2017
Q2 | $2.99M | Buy |
53,240
+1,407
| +3% | +$79K | ﹤0.01% | 970 |
|
2017
Q1 | $2.03M | Buy |
51,833
+19,460
| +60% | +$763K | ﹤0.01% | 1038 |
|
2016
Q4 | $726K | Buy |
32,373
+3,216
| +11% | +$72.1K | ﹤0.01% | 1193 |
|
2016
Q3 | $662K | Sell |
29,157
-13,586
| -32% | -$308K | ﹤0.01% | 1231 |
|
2016
Q2 | $1.01M | Sell |
42,743
-5,791
| -12% | -$137K | ﹤0.01% | 1135 |
|
2016
Q1 | $990K | Sell |
48,534
-14,771
| -23% | -$301K | ﹤0.01% | 1102 |
|
2015
Q4 | $3.26M | Buy |
63,305
+10,580
| +20% | +$544K | ﹤0.01% | 938 |
|
2015
Q3 | $2.25M | Buy |
52,725
+12,307
| +30% | +$524K | ﹤0.01% | 1002 |
|
2015
Q2 | $1.84M | Buy |
40,418
+8,896
| +28% | +$405K | ﹤0.01% | 1042 |
|
2015
Q1 | $1.2M | Sell |
31,522
-3,308
| -9% | -$126K | ﹤0.01% | 1123 |
|
2014
Q4 | $986K | Buy |
34,830
+1,519
| +5% | +$43K | ﹤0.01% | 1190 |
|
2014
Q3 | $842K | Buy |
33,311
+1,782
| +6% | +$45K | ﹤0.01% | 1214 |
|
2014
Q2 | $920K | Buy |
+31,529
| New | +$920K | ﹤0.01% | 1233 |
|